United Financial Group is an investment platform that has been in existence since 2019. We are engaged in financing and our own developments in the most innovative areas: biotechnology, anti-cancer drugs, dietary supplements, IT developments
Anyone can invest within our company. Unlike many investment funds, we provide a comfortable payment amount and the possibility of installments.
The company already has its own production of dietary supplements of the Rusich line, which are available for purchase in the online store ufgmarket
Recently, there has been a stagnation of business all over the world and the closure of many projects, the bankruptcy of companies and the loss of investments by people.
But even in such conditions, the UFG Company is looking for opportunities and means to continue its scientific research and promote its products to the market.
The market of medicines and dietary supplements is very saturated and it is very difficult to promote something new to it, but the company is systematically moving towards the withdrawal of its drugs on different sites. In 2023, the company has already presented its products at such sites as:
III Art and Industrial Exhibition-Forum "Unique Russia"
VIII International Exhibition of Nutritional Supplements and Healthy Nutrition
14th Federal Healthy Lifestyle Exhibition "VEG-LIFE expo"
On which the provided preparations of the RUSIC line received the appropriate diplomas.
The company issues information on the fact of the cases.
UFG continues its growth path even in the current difficult financial and political environment.
Our main product is Alginar for the treatment of oncology, and not herbal products, which we simultaneously took to work, as there are good results and a good product in general.
On the development of the drug "Alginar" almost all scientific research has been completed and the first trial batches of the drug have already been made in the laboratory. Opportunities are currently being sought to place an order for the production of Antarctic black yeast Nadsoniellanigra var.hesuelica, the initial product for the production of Alginar.
It was decided to place an order on outsourcing terms, to a third-party organization, since purchasing our own equipment and producing it on our own requires huge financial investments.
Investments in UFG Company are long-term and there is no way to expect instant dividends. Since the development and implementation of new medicines is a process of more than one or two years and requires very large financial investments. But the profitability of such developments is presented in the presentation.
Against the background of today's realities of instability in the world, the company does not have an option in which, for example, $ 100,000 would be received by the company every month, the company's financing is limited, it is difficult to plan business processes.
We work with what we have, but the company has a highly developed business process optimization, without which all the funds would not even be enough to research Alginar and develop its production technology.
On August 9, we represented the company at a very interesting event organized by MAP (Moscow Association of Entrepreneurs).
UFG Company was invited to join this association.
A very serious organization with more than 500 companies
with their state programs, support, budget projects, access to other markets, etc.
The line of preparations "Rusich" interested many, and the deputy. President MAP proposed to promote the brand "Rusich" within the organization, in addition, there were other proposals.
At the forum, a gift was presented, a set of products "Rusich" to the Ambassador of Nicaragua in Russia.
In the UFG company, in the development of drugs for human health, people invest who understand the prospects for the development of this area. They do not expect instant and quick dividends, but they know that every penny or Cent invested in the project saves someone's life!
Full information on created drugs and developments is available on the ufgpro.com website, and when registering a personal account, you will have access to all information on investing and purchasing developed drugs on favorable terms for investors.